1 min read

Pfizer CentreOne: Ready to meet your complex OSD needs, seamlessly and simply.

1 min read

To meet the demands of the oral solid dosage (OSD) market, new techniques and technologies have emerged. While these have allowed developers to break new ground in harnessing innovative active pharmaceutical ingredients (APIs), the production of OSD therapeutics has become more and more complicated.

At Pfizer CentreOne, we help make the complex simple.

We leverage our state-of-the-art facilities and decades of experience to deliver high-quality OSD products — including highly potent, cytotoxic and low bioavailability drugs — to support even the most challenging OSD products. This application note explores the OSD production and manufacturing methods we use to help achieve your goals.

You can download the full application note by completing the form below.

Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.